2025-11-17T14:58:56-06:00 2024-12-31 581763570 JONES AND KOLB 3475 PIEDMONT ROAD NE SUITE 1500 ATLANTA GA 30305 990 2024-01-01 800419218 SOCIETY ON SARCOPENIA CACHEXIA AND WASTING DISORDERS INC (SCWD) SOCI 6782315525 3780 OLD NORCROSS RD 103501 DULUTH GA 300961740 TERESA MCREYNOLDS SECRETARY 6782315525 2025-11-17 1 0 LAURA H HELLER P00744874 4042627920 2024 2025-03-06 01:10:19Z YANN COLARDELLE 3780 OLD NORCROSS RD 103501 DULUTH GA 300961740 373013 0 X WWW.CACHEXIA.ORG X 2008 GA INCREASE PUBLIC AWARENESS OF SARCOPENIA, CACHEXIA AND WASTING DISORDERS THROUGH THE DEVELOPMENT OF AN ONLINE PLATFORM THAT WILL DISSEMINATE INFORMATION ABOUT SARCOPENIA, CACHEXIA AND WASTING DISEASES. 23 23 0 25 168500 0 304399 204513 0 168500 0 0 0 0 304399 373013 0 0 0 0 0 0 0 0 0 296667 421953 296667 421953 7732 -48940 119370 70430 4200 4200 115170 66230 X INCREASED PUBLIC AWARENESS OF SACROPENIA CACHEXIA AND WASTING DISORDER THROUGTH THE DEVELOPMENT OF EDUCATIONAL MEETINGS. 0 0 326912 168500 IN 2024, THE SOCIETY FOR CACHEXIA, WASTING, AND SARCOPENIA DISORDERS (SCWD) CONTINUED ITS IMPACTFUL INITIATIVES, NOTABLY THROUGH ITS 17TH CACHEXIA CONFERENCE HELD IN WASHINGTON. THE EVENT BROUGHT TOGETHER 340 PARTICIPANTS FROM 27 COUNTRIES, FEATURING 166 POSTER ABSTRACTS. THIS CONFERENCE MARKED SIGNIFICANT INTERNATIONAL COLLABORATION, WITH REPRESENTATIVES FROM THE USA, GERMANY, AND THE UK LEADING THE WAY IN POSTER SUBMISSIONS. 69468 IN 2024, SCWD SUPPORTED A PIVOTAL STUDY CONDUCTED IN FRANCE ON THE PREVALENCE OF CANCER CACHEXIA, WHICH WAS FOUND TO BE SIGNIFICANTLY UNDERESTIMATED IN MEDICAL RECORDS. THE RESEARCH, CONDUCTED AT THE ROUEN UNIVERSITY HOSPITAL, USED A CLINICAL DATA WAREHOUSE TO ANALYZE BOTH STRUCTURED (ICD CODES) AND UNSTRUCTURED (CLINICAL NARRATIVES) DATA FROM 2018-2023. THE STUDY REVEALED THAT MANY CASES OF CANCER CACHEXIA WERE EITHER NOT DIAGNOSED OR MISCLASSIFIED DUE TO INCOMPLETE OR INACCURATE DOCUMENTATION, PARTICULARLY IN RELATION TO WEIGHT LOSS DATA. AMONG PATIENTS WITH HIGH-PREVALENCE CACHEXIA CANCERS LIKE COLORECTAL, PANCREATIC, AND LUNG CANCERS, THE PREVALENCE WAS FOUND TO BE 29.3%, MUCH HIGHER THAN THE 3.66% IDENTIFIED BY ICD CODING ALONE. THE FINDINGS UNDERSCORE THE NEED FOR IMPROVED AWARENESS AND CODING PRACTICES, AS ACCURATE DIAGNOSIS IS ESSENTIAL FOR TIMELY INTERVENTIONS AND CLINICAL TRIALS 12259 SCWD STRENGTHENED ITS ACADEMIC PRESENCE THROUGH THE JOURNAL OF CACHEXIA, SARCOPENIA, AND MUSCLE (JCSM), WITH THE JOURNAL CONTINUING TO BE A PROMINENT PLATFORM FOR HIGH-QUALITY RESEARCH IN THE FIELD, WITH A 9.4 IMPACT FACTOR IN 2023. ADDITIONALLY, THE SOCIETY EXPANDED ITS MEMBERSHIP, REACHING 86 PAYING MEMBERS BY THE END OF THE YEAR, FURTHER ADVANCING ITS MISSION TO FOSTER COLLABORATION AND INNOVATION IN THE FIELD OF CACHEXIA AND RELATED DISORDERS. 408639 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 23 23 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 1 1 0 GA X YANN COLARDELLE 6782315525 3780 OLD NORCROSS RD 103501 DULUTH GA 300961740 X STEFAN ANKER PRESIDENT 1.00 X X 0 0 0 WILLIAM EVANS FOUNDING DIRECTOR 1.00 X X 0 0 0 JOSEP M ARGILES FOUNDING DIRECTOR 1.00 X X 0 0 0 AMINAH JATOI DIRECTOR 1.00 X 0 0 0 DAVID GLASS DIRECTOR 1.00 X 0 0 0 FLORIAN STRASSER DIRECTOR 1.00 X 0 0 0 KAMYAR KALANTAR-ZADEH DIRECTOR 1.00 X 0 0 0 STEPHAN VON HAEHLING DIRECTOR 1.00 X 0 0 0 VICKIE BARACOS DIRECTOR 1.00 X 0 0 0 HIDENORI ARAI DIRECTOR 1.00 X 0 0 0 HIDETAKA WAKABAYASHI DIRECTOR 1.00 X 0 0 0 WOLFRAM DOEHNER DIRECTOR 1.00 X 0 0 0 MAURIZIO MUSCARITOLI DIRECTOR 1.00 X 0 0 0 IVAN APRAHAMIAN DIRECTOR 1.00 X 0 0 0 JAMES CARSON DIRECTOR 1.00 X 0 0 0 ANDREW JS COATS DIRECTOR 1.00 X 0 0 0 JEFF CRAWFORD DIRECTOR 1.00 X 0 0 0 GUSTAVO DUQUE DIRECTOR 1.00 X 0 0 0 MITJA LAINSCAK DIRECTOR 1.00 X 0 0 0 BARRY LAIRD DIRECTOR 1.00 X 0 0 0 RESHMA MERCHANT DIRECTOR 1.00 X 0 0 0 RICHARD SKIPWORTH DIRECTOR 1.00 X 0 0 0 BEN KIRK DIRECTOR 1.00 X 0 0 0 YANN COLARDELLE CFO 10.00 X 0 0 0 TERESA MCREYNOLDS SECRETARY 1.00 X 0 0 0 0 0 0 0 0 0 0 THE VIBE AGENCY 11098 BISCAYNE BLVD STE 201 MIAMI FL 33131 LOGISTICS 216628 1 204513 204513 CONFERENCE REGISTRATIO 541900 168500 168500 168500 373013 0 168500 0 X 3030 3030 6000 6000 161282 161282 18298 18298 4360 2500 1860 226559 226559 BANK FEES 2109 2109 FEES 315 315 421953 408639 13314 0 119370 70430 119370 70430 4200 4200 4200 4200 X 115170 66230 115170 66230 119370 70430 -48940 0 X 0 0 0 X 369430 117684 381819 304399 204514 1377846 168500 168500 369430 117684 381819 304399 373014 1546346 0 0 0 1546346 369430 117684 381819 304399 373014 1546346 1.00000 0.96180 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 1 0 PROGRAM SERVICES IN 2024, SCWD SUPPORTED A PIVOTAL STUDY CONDUCTED IN FRANCE ON THE PREVALENCE OF CANCER CACHEXIA, WHICH WAS FOUND TO BE SIGNIFICANTLY UNDERESTIMATED IN MEDICAL RECORDS. THE RESEARCH, CONDUCTED AT THE ROUEN UNIVERSITY HOSPITAL, USED A CLINICAL DATA WAREHOUSE TO ANALYZE BOTH STRUCTURED (ICD CODES) AND UNSTRUCTURED (CLINICAL NARRATIVES) DATA FROM 2018-2023. THE STUDY REVEALED THAT MANY CASES OF CANCER CACHEXIA WERE EITHER NOT DIAGNOSED OR MISCLASSIFIED DUE TO INCOMPLETE OR INACCURATE DOCUMENTATION, PARTICULARLY IN RELATION TO WEIGHT LOSS DATA. AMONG PATIENTS WITH HIGH-PREVALENCE CACHEXIA CANCERS LIKE COLORECTAL, PANCREATIC, AND LUNG CANCERS, THE PREVALENCE WAS FOUND TO BE 29.3%, MUCH HIGHER THAN THE 3.66% IDENTIFIED BY ICD CODING ALONE. THE FINDINGS UNDERSCORE THE NEED FOR IMPROVED AWARENESS AND CODING PRACTICES, AS ACCURATE DIAGNOSIS IS ESSENTIAL FOR TIMELY INTERVENTIONS AND CLINICAL TRIALS 69468 1 0 0 0 1 0 69468 0 69468 0 0 0 0 0 0 LMS GROUP LLC YANN COLARDELLE, CFO OF SCWD IS A MAJORITY OWNER OF LMS GROUP 48794 SOCIETY ON SARCOPENIA CACHEXIA AND WASTING DISORDERS, INC. APPOINTS LMS TO LOOK FOR AND IMPLEMENT GRANTS IN THE FIELD OF CACHEXIA AND SARCOPENIA. LMS GROUP INC WILL CARRY OUT THE FOLLOWING MISSION DURING THE DURATION OF THEIR AGREEMENT:- TO CONTACT THE HEALTH INDUSTRY BY PRESENTING THE PROGRAMS DEVELOPED BY SCWD- TO NEGOTIATE AND IMPLEMENT CONTRACTS WITH GRANTORS FOR THE BEHALF OF SCWD,- TO TAKE CHARGE OF THE ADMINISTRATIVE PROCESS OF THE GRANT SUBMISSION REQUESTED BY THE GRANTORS,- TO OVERSEE THE PAYMENT OF GRANTS BY THE GRANTORS AND ENSURE PAYMENT REMINDERS IF NECESSARY. 0 FORM 990, PART VI, SECTION A, LINE 8B COMMITTEE MEETING NOTES ARE PROVIDED TO THE BOARD FOR REVIEW. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE OFFICERS AND PROVIDED TO ALL BOARD MEMBERS FOR REVIEW AND APPROVAL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REVIEWS THE CONFLICT OF INTEREST STATEMENT AT ANNUAL MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD REVIEWS ALL COMPENSATION PAYMENTS TO OFFICERS AND KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AT THE ORGANIZATION'S OFFICE. FORM 990, PART IX, LINE 11G PROJECT DEVELOPMENT AND MANAGEMENT: PROGRAM SERVICE EXPENSES 32,523. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 32,523. COMMISSION: PROGRAM SERVICE EXPENSES 48,794. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 48,794. CONSULTANTS: PROGRAM SERVICE EXPENSES 18,300. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 18,300. SCIENTIFIC REVIEW: PROGRAM SERVICE EXPENSES 61,665. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 61,665.